379 related articles for article (PubMed ID: 27908680)
41. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
[TBL] [Abstract][Full Text] [Related]
42. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
43. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
Guo RQ; Hong P; Xiong GY; Zhang L; Fang D; Li XS; Zhang K; Zhou LQ
BJU Int; 2018 Feb; 121(2):184-193. PubMed ID: 29032580
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
Sung HH; Jeon HG; Han DH; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
PLoS One; 2015; 10(11):e0139976. PubMed ID: 26556239
[TBL] [Abstract][Full Text] [Related]
45. The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.
Momota M; Hatakeyama S; Tokui N; Sato T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Narita S; Kawaguchi T; Ohyama C
Eur Urol Focus; 2019 Nov; 5(6):1066-1073. PubMed ID: 29548907
[TBL] [Abstract][Full Text] [Related]
46. Segmental Ureterectomy is Acceptable for High-risk Ureteral Carcinoma Comparing to Radical Nephroureterectomy.
Huang Z; Zhang X; Zhang X; Li Q; Liu S; Yu L; Xu T
J Invest Surg; 2019 Dec; 32(8):746-753. PubMed ID: 29693458
[No Abstract] [Full Text] [Related]
47. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
[TBL] [Abstract][Full Text] [Related]
48. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
[TBL] [Abstract][Full Text] [Related]
49. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A
Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830
[TBL] [Abstract][Full Text] [Related]
50. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
[TBL] [Abstract][Full Text] [Related]
51. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
[TBL] [Abstract][Full Text] [Related]
52. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
53. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
[TBL] [Abstract][Full Text] [Related]
54. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
Kim HS; Lee JS; Jeong CW; Kwak C; Kim HH; Ku JH
Int Braz J Urol; 2015; 41(6):1067-79. PubMed ID: 26742963
[TBL] [Abstract][Full Text] [Related]
56. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
[TBL] [Abstract][Full Text] [Related]
57. Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs.
Del Giudice F; van Uem S; Li S; Vilson FL; Sciarra A; Salciccia S; Busetto GM; Maggi M; Tiberia L; Viscuso P; Canale V; Panebianco V; Pecoraro M; Ferro M; Moschini M; Krajewski W; D'Andrea D; Cacciamani GE; Mari A; Soria F; Porpiglia F; Fiori C; Amparore D; Checcucci E; Autorino R; De Berardinis E; Chung BI
Clin Genitourin Cancer; 2022 Apr; 20(2):198.e1-198.e9. PubMed ID: 35031226
[TBL] [Abstract][Full Text] [Related]
58. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
[TBL] [Abstract][Full Text] [Related]
59. The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
Pinar U; Calleris G; Grobet-Jeandin E; Grande P; Benamran D; Thibault C; Gontero P; Rouprêt M; Seisen T
World J Urol; 2023 Nov; 41(11):3205-3230. PubMed ID: 36905443
[TBL] [Abstract][Full Text] [Related]
60. Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.
Hoshino K; Kikuchi E; Tanaka N; Akita H; Ito Y; Miyajima A; Jinzaki M; Oya M
Jpn J Clin Oncol; 2012 Mar; 42(3):202-7. PubMed ID: 22246718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
